
Sign up to save your podcasts
Or


For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/PHX865. CME credit will be available until May 23, 2025.
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Sanofi.
Disclosure information is available at the beginning of the video presentation.
By PVI, PeerView Institute for Medical Education4
1010 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/PHX865. CME credit will be available until May 23, 2025.
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Sanofi.
Disclosure information is available at the beginning of the video presentation.

134 Listeners

320 Listeners

498 Listeners

40 Listeners

27 Listeners

10 Listeners

5 Listeners

10 Listeners

4 Listeners

2 Listeners

5 Listeners

2 Listeners

3 Listeners

5 Listeners

5 Listeners

2 Listeners

0 Listeners

9 Listeners

2 Listeners

115 Listeners

2 Listeners

4 Listeners

57 Listeners

3 Listeners

5 Listeners

3,336 Listeners

44 Listeners

22 Listeners

2 Listeners

365 Listeners

54 Listeners

58 Listeners

189 Listeners